Loading
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nancy Stuart (senior executive) discloses dealings in Concert Pharmaceuticals, Inc. to SEC (Form 4). Between 5 January 2022 and 6 March 2023, the trades on record add up to 7 filings.
No open-market purchase appears, only 5 sales worth €193k. Besides market trades, the filings include 1 share grant. So far in 2023, the count stands at no purchases and 3 sales.
The record was last updated on 6 March 2023 with a transaction in Concert Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations